266 related articles for article (PubMed ID: 32430930)
1. Nociceptive responses in melatonin MT
Posa L; Lopez-Canul M; Rullo L; De Gregorio D; Dominguez-Lopez S; Kaba Aboud M; Caputi FF; Candeletti S; Romualdi P; Gobbi G
J Pineal Res; 2020 Oct; 69(3):e12671. PubMed ID: 32430930
[TBL] [Abstract][Full Text] [Related]
2. Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.
Comai S; Ochoa-Sanchez R; Gobbi G
Behav Brain Res; 2013 Apr; 243():231-8. PubMed ID: 23333399
[TBL] [Abstract][Full Text] [Related]
3. Melatonin MT
López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
[TBL] [Abstract][Full Text] [Related]
4. Melatonin receptor deficiency decreases and temporally shifts ecto-5'-nucleotidase mRNA levels in mouse prosencephalon.
Homola M; Pfeffer M; Robson SC; Fischer C; Zimmermann H; Korf HW
Cell Tissue Res; 2016 Jul; 365(1):147-56. PubMed ID: 26917036
[TBL] [Abstract][Full Text] [Related]
5. Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors.
Imbesi M; Uz T; Dzitoyeva S; Giusti P; Manev H
Brain Res; 2008 Aug; 1227():19-25. PubMed ID: 18621029
[TBL] [Abstract][Full Text] [Related]
6. Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury.
Wu N; Carpino G; Ceci L; Baiocchi L; Francis H; Kennedy L; Zhou T; Chen L; Sato K; Kyritsi K; Meadows V; Ekser B; Franchitto A; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Hepatology; 2022 Apr; 75(4):797-813. PubMed ID: 34743371
[TBL] [Abstract][Full Text] [Related]
7. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
[TBL] [Abstract][Full Text] [Related]
8. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Imbesi M; Uz T; Manev H
Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
[TBL] [Abstract][Full Text] [Related]
9. The endogenous melatonin (MT) signal facilitates reentrainment of the circadian system to light-induced phase advances by acting upon MT2 receptors.
Pfeffer M; Rauch A; Korf HW; von Gall C
Chronobiol Int; 2012 May; 29(4):415-29. PubMed ID: 22489607
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
López-Canul M; Comai S; Domínguez-López S; Granados-Soto V; Gobbi G
Eur J Pharmacol; 2015 Oct; 764():424-432. PubMed ID: 26162699
[TBL] [Abstract][Full Text] [Related]
11. Heteromeric MT1/MT2 melatonin receptors modulate photoreceptor function.
Baba K; Benleulmi-Chaachoua A; Journé AS; Kamal M; Guillaume JL; Dussaud S; Gbahou F; Yettou K; Liu C; Contreras-Alcantara S; Jockers R; Tosini G
Sci Signal; 2013 Oct; 6(296):ra89. PubMed ID: 24106342
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.
Clough SJ; Hutchinson AJ; Hudson RL; Dubocovich ML
Physiol Behav; 2014 Jun; 132():79-86. PubMed ID: 24813704
[TBL] [Abstract][Full Text] [Related]
13. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep.
Gobbi G; Comai S
J Pineal Res; 2019 Apr; 66(3):e12544. PubMed ID: 30586215
[TBL] [Abstract][Full Text] [Related]
14. Food-induced reinforcement is abrogated by the genetic deletion of the MT
Clough SJ; Hudson RL; Dubocovich ML
Behav Brain Res; 2018 May; 343():28-35. PubMed ID: 29374562
[TBL] [Abstract][Full Text] [Related]
15. Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway.
Sharan K; Lewis K; Furukawa T; Yadav VK
J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28512916
[TBL] [Abstract][Full Text] [Related]
16. Melatonin MT
Chen M; Cecon E; Karamitri A; Gao W; Gerbier R; Ahmad R; Jockers R
J Pineal Res; 2020 May; 68(4):e12641. PubMed ID: 32080899
[TBL] [Abstract][Full Text] [Related]
17. MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations.
Klosen P; Lapmanee S; Schuster C; Guardiola B; Hicks D; Pevet P; Felder-Schmittbuhl MP
J Pineal Res; 2019 Aug; 67(1):e12575. PubMed ID: 30937953
[TBL] [Abstract][Full Text] [Related]
18. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
Stein RM; Kang HJ; McCorvy JD; Glatfelter GC; Jones AJ; Che T; Slocum S; Huang XP; Savych O; Moroz YS; Stauch B; Johansson LC; Cherezov V; Kenakin T; Irwin JJ; Shoichet BK; Roth BL; Dubocovich ML
Nature; 2020 Mar; 579(7800):609-614. PubMed ID: 32040955
[TBL] [Abstract][Full Text] [Related]
19. Melatonin receptor heterodimerization in a photoreceptor-like cell line endogenously expressing melatonin receptors.
Sánchez-Bretaño A; Suen TC; Baba K; DeBruyne J; Tosini G
Mol Vis; 2019; 25():791-799. PubMed ID: 31819341
[TBL] [Abstract][Full Text] [Related]
20. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
